In the liver, a lack of curcumin results in increased SREBP1c-driven lipogenesis and suppressed β-oxidation via PPARα activation, along with aggravated NF-κB/TGF-β signaling and reduced insulin sensitivity, leading to steatosis and fibrosis. The gene discussed is SREBF1; the disease is steatosis.